4.3 Review

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

期刊

JOURNAL OF PSYCHOPHARMACOLOGY
卷 26, 期 6, 页码 753-765

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881111412095

关键词

Attention-deficit hyperactivity disorder; diagnosis; guidelines; therapeutics

资金

  1. Janssen-Cilag
  2. Eli Lilly
  3. Shire
  4. Purdue

向作者/读者索取更多资源

During the last few years several clinical guidelines on attention-deficit hyperactivity disorder (ADHD) have been published by national and international medical societies. To systematically review and compare recommendations of selected ADHD guidelines, we performed a systematic search in online guideline databases and PubMed in order to retrieve guideline texts. Guidelines meeting inclusion criteria were reviewed and recommendations on assessment and treatment extracted. The AGREE instrument was used to assess methodological quality. Of the 26 guidelines identified, 13 were selected for further analysis: 11 guidelines deal with ADHD in childhood and adolescence and 5 guidelines cover transitional patients and/or ADHD in adults. The methodological quality of ADHD guidelines is moderate to good. They reflect similarities and differences of healthcare systems. Diagnosis throughout the lifespan is based on a detailed clinical history. There is greater agreement on evidence-based pharmacological treatment than on psychosocial interventions, reflecting the strength of evidence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Developmental

The Functional Impact of Sleep Disorders in Children With ADHD

Stephanie G. Craig, Margaret D. Weiss, Kristen L. Hudec, Christopher Gibbins

JOURNAL OF ATTENTION DISORDERS (2020)

Article Psychology, Developmental

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension

Margaret D. Weiss, Ann C. Childress, Graeme A. E. Donnelly

Summary: PRC-063 demonstrated good tolerability and significant improvement in ADHD symptoms in adults, with a notable impact on symptom reduction. There was no significant impact on sleep quality.

JOURNAL OF ATTENTION DISORDERS (2021)

Article Neurosciences

Attention-deficit/hyperactivity disorder and the explore/exploit trade-off

Merideth A. Addicott, John M. Pearson, Julia C. Schechter, Jeffrey J. Sapyta, Margaret D. Weiss, Scott H. Kollins

Summary: This study found that individuals with ADHD tend to make more exploratory decisions and methylphenidate does not alter this behavior. Exploratory choices are positively associated with ADHD symptoms, suggesting that unexplained variance in ADHD decisions may be due to insufficient value tracking.

NEUROPSYCHOPHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Reviewing the role of emerging therapies in the ADHD armamentarium

Ann C. Childress, Nathalie Beltran, Carl Supnet, Margaret D. Weiss

Summary: The review discusses the development of new stimulant and nonstimulant formulations, particularly those in phase II and III trials. It describes the efficacy, mechanism of action, and adverse effect data of these medications, as well as the abuse liability studies for abuse-deterrent formulations in development. The review highlights a strong pipeline of stimulant and nonstimulant drugs designed to offer improvements in onset and duration of effect, administration timing, and deterrence of abuse.

EXPERT OPINION ON EMERGING DRUGS (2021)

Article Psychology, Developmental

The Association between ADHD and the Severity of COVID-19 Infection

Eugene Merzon, Margaret D. Weiss, Samuele Cortese, Ann Rotem, Tzipporah Schneider, Stephanie G. Craig, Shlomo Vinker, Avivit Golan Cohen, Ilan Green, Shai Ashkenazi, Abraham Weizman, Iris Manor

Summary: Age, male sex, and BMI were significant risk factors for increased COVID-19 severity, while ADHD was associated with more severe symptoms and referral to hospitalization in COVID-19 infection.

JOURNAL OF ATTENTION DISORDERS (2022)

Article Clinical Neurology

Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension

Margaret Danielle Weiss, Craig Surman, Atul Khullar, Ellie He, Marc Cataldo, Graeme Donnelly

Summary: On average, PRC-063 had no significant impact on overall sleep quality in adults with ADHD. However, when measuring sleep as an outcome in its own right, more patients showed improvement in sleep than deterioration under dose-optimized open-label treatment.

CNS DRUGS (2021)

Article Pediatrics

Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up

Margaret Danielle Weiss, Craig Surman, Atul Khullar, Judith Owens, Ellie He, Marc Cataldo, Graeme Donnelly

Summary: The study analyzed the impact of extended-release methylphenidate on sleep parameters in adolescents with attention-deficit/hyperactivity disorder. Results showed a trend of improvement in sleep quality with PRC-063 that was maintained over 6 months, with no significant differences reported in self-reported sleep outcomes between PRC-063 and placebo on the PSQI scale.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2021)

Article Pediatrics

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

Margaret D. Weiss, Andrew J. Cutler, Scott H. Kollins, Graeme A. E. Donnelly

Summary: PRC-063 significantly improved ADHD symptomatology in adolescents, especially in the 45 mg and 70 mg dose groups. Some participants were identified as responders based on CGI-I assessment. Further improvements in ADHD symptoms were observed during open-label treatment from 1 month through 6 months.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2021)

Article Environmental Sciences

Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study

Eugene Merzon, Margaret Weiss, Beth Krone, Shira Cohen, Gili Ilani, Shlomo Vinker, Avivit Cohen-Golan, Ilan Green, Ariel Israel, Tzipporah Schneider, Shai Ashkenazi, Abraham Weizman, Iris Manor

Summary: This study examines the factors associated with diagnosis of long COVID syndrome in children. The findings show that children with long COVID syndrome are more likely to have severe symptoms, require hospitalization, and have recurrent acute infections. They are also more likely to have ADHD, chronic urticaria, and allergic rhinitis. The study suggests that clinicians should be vigilant for the possibility of long COVID syndrome in children with pre-existing ADHD. Further research on morbidity related to long COVID syndrome in children is needed.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Neurosciences

A Paradigm for Targeting Functional Impairment as an Outcome in Attention-Deficit/Hyperactivity Disorder

Margaret Danielle Weiss

Summary: The time frame and definition of functional impairment in DSM 5 is ambiguous. Functional impairment can be classified as a stable trait or a state sensitive to emotional or behavior problems. Treatment outcome measures of functional impairment include change from baseline and status at treatment endpoint.

BRAIN SCIENCES (2022)

Editorial Material Psychology, Developmental

Editorial: Longitudinal Associations Between Sleep and ADHD Symptoms: ADHD Is a 24-Hour Disorder

Mark A. Stein, Margaret D. Weiss

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2023)

Article Psychiatry

Receiver operating characteristic curve analysis of the Weiss Functional Impairment Rating Scale-Parent Report for screening children with ADHD: Looking beyond symptoms in ADHD diagnosis

Behnaz Kiani, Habib Hadianfard, Margaret D. Weiss, Sara Dehbozorgi

Summary: The aim of this study was to examine the ability of the WFIRS-P to assess functional impairment in children with ADHD and determine optimal cutoff scores. The results showed that the WFIRS-P had good discriminatory ability, but low sensitivity in the self-concept and life skills subscales.

EARLY INTERVENTION IN PSYCHIATRY (2023)

Article Health Care Sciences & Services

Defragmenting the path to diagnosis for underserved youth with Autism Spectrum Disorder in a community-based health system

Lee A. Robinson, Laura Gaugh, Scott Yapo, Rami Al-Sumairi, Aileen Lorenzo, Margaret Weiss

Summary: Autism Spectrum Disorder (ASD) is a common neurodevelopmental disorder that poses challenges for many youth, especially those from disadvantaged backgrounds. This study presents a quality improvement initiative aimed at addressing the barriers faced by underserved families seeking a timely diagnosis of ASD.

HEALTHCARE-THE JOURNAL OF DELIVERY SCIENCE AND INNOVATION (2022)

Article Psychiatry

Study of Functional Impairment in Students of Elementary and Secondary Public Schools in Iran

Habib Hadianfard, Behnaz Kiani, Margaret D. Weiss

Summary: The study found that 11.9% of children and 29.5% of adolescents showed impairment in at least two functional domains, with life skills being the most frequent impaired domain. While no significant sex and age effects were found during childhood, male adolescents showed more impairment in externalizing domains, and female adolescents showed more internalizing difficulties. In addition, older adolescents showed more functional impairment relative to younger adolescents.

JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2021)

Article Pharmacology & Pharmacy

Is Functional Improvement Always Correlated with Symptomatic Improvement in Children with Attention-Deficit/Hyperactivity Disorder Managed with Oros Methylphenidate? A Prospective Open-Label Naturalistic Follow-Up Study

Mahmut Cem Tarakcioglu, Yasin Caliskan, Muhammed Tayyib Kadak, Nilufer Okumus Aliyev, Umut Mert Aksoy, Ali Evren Tufan, Ozlem Yildiz Gundogdu, Nursu Cakin Memik, Margaret D. Weiss

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY (2020)

暂无数据